Trial Condition(s):
Magnetic Resonance Imaging
Magnevist enteral in magnetic resonance imaging
Bayer Identifier:
Trial_AC94
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
125
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
Status
| Locations | Status |
|---|
For details, please refer to trial results
Additional Information
Not Available
Copyright © Bayer
Powered by
